Lymphoma Researchers Earn Top 10 Clinical Research Award
Thursday, April 14, 2016
Source: Weill Cornell Medical College
The study "Lenalidomide plus Rituximab as Initial Treatment for Mantle Cell Lymphoma," led by first author Dr. Jia Ruanand senior author Dr. John Leonard, was published Nov. 5, 2015 in the New England Journal of Medicine. The study demonstrates that the pill Lenalidomide, taken in combination with the antibody Rituximab, effectively manages the disease — a cancer of the white blood cells that primarily affects the elderly — without the typical debilitating effects of chemotherapy, inducing remissions in the vast majority of patients.
The forum conducts an annual, national competition to determine 10 outstanding clinical research accomplishments in the United States that are both innovative and have a substantial effect on human disease. In recognition of the 2016 clinical research awards, the winners presented their findings on April 12 at the annual Clinical Research Forum meeting in Washington, D.C.